$76.10
At close: Mar 27, 11:12 AM EDT
Comments
Loading...
Zealand Pharma Analyst Ratings and Price Targets | OTC:ZLDPF | Benzinga
Zealand Pharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Zealand Pharma Corp from these most-recent analyst ratings.
Analyst Ratings for Zealand Pharma
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Zealand Pharma (ZLDPF) stock?
There is no price target for Zealand Pharma
What is the most recent analyst rating for Zealand Pharma (ZLDPF)?
There is no analyst for Zealand Pharma
When was the last upgrade for Zealand Pharma (ZLDPF)?
There is no last upgrade for Zealand Pharma
When was the last downgrade for Zealand Pharma (ZLDPF)?
There is no last downgrade for Zealand Pharma.
When is the next analyst rating going to be posted or updated for Zealand Pharma (ZLDPF)?
There is no next analyst rating for Zealand Pharma.
Is the Analyst Rating Zealand Pharma (ZLDPF) correct?
There is no next analyst rating for Zealand Pharma.
Browse analyst ratings and price targets on all stocks.